TMEM223
gene geneOn this page
Also known as MGC3196Mrx15
Summary
TMEM223 (transmembrane protein 223, HGNC:28464) is a protein-coding gene on chromosome 11q12.3, encoding Transmembrane protein 223 (A0PJW6). Mitochondrial ribosome-associated protein involved in the first steps of cytochrome c oxidase complex (complex IV) biogenesis.
Enables mitochondrial ribosome binding activity. Involved in mitochondrial cytochrome c oxidase assembly. Located in mitochondrion. Is active in mitochondrial inner membrane.
Source: NCBI Gene 79064 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 47 total
- MANE Select transcript:
NM_001080501
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28464 |
| Approved symbol | TMEM223 |
| Name | transmembrane protein 223 |
| Location | 11q12.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC3196, Mrx15 |
| Ensembl gene | ENSG00000168569 |
| Ensembl biotype | protein_coding |
| OMIM | 620434 |
| Entrez | 79064 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 4 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000307366, ENST00000525631, ENST00000527073, ENST00000528367, ENST00000913614
RefSeq mRNA: 1 — MANE Select: NM_001080501
NM_001080501
CCDS: CCDS44628
Canonical transcript exons
ENST00000307366 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001141945 | 62791679 | 62792006 |
| ENSE00001141951 | 62789971 | 62790915 |
Expression profiles
Bgee: expression breadth ubiquitous, 161 present calls, max score 90.46.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 18.7648 / max 75.8520, expressed in 1773 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 120234 | 18.7648 | 1773 |
Top tissues by expression
249 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 90.46 | gold quality |
| apex of heart | UBERON:0002098 | 89.59 | gold quality |
| right adrenal gland | UBERON:0001233 | 88.73 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 88.55 | gold quality |
| granulocyte | CL:0000094 | 88.48 | gold quality |
| left adrenal gland | UBERON:0001234 | 88.38 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 87.91 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.42 | gold quality |
| heart left ventricle | UBERON:0002084 | 87.12 | gold quality |
| metanephros cortex | UBERON:0010533 | 86.64 | gold quality |
| body of pancreas | UBERON:0001150 | 86.28 | gold quality |
| right lobe of liver | UBERON:0001114 | 86.19 | gold quality |
| right frontal lobe | UBERON:0002810 | 86.08 | gold quality |
| right atrium auricular region | UBERON:0006631 | 86.05 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 85.98 | gold quality |
| transverse colon | UBERON:0001157 | 85.90 | gold quality |
| body of stomach | UBERON:0001161 | 85.75 | gold quality |
| cardiac ventricle | UBERON:0002082 | 85.55 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 85.29 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 85.19 | gold quality |
| adrenal cortex | UBERON:0001235 | 85.08 | gold quality |
| cardiac atrium | UBERON:0002081 | 84.90 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 84.80 | gold quality |
| adenohypophysis | UBERON:0002196 | 84.71 | gold quality |
| adrenal gland | UBERON:0002369 | 84.64 | gold quality |
| muscle of leg | UBERON:0001383 | 84.56 | gold quality |
| gastrocnemius | UBERON:0001388 | 84.49 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 84.42 | gold quality |
| minor salivary gland | UBERON:0001830 | 84.39 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 84.12 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.52 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
12 targeting TMEM223, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5193 | 100.00 | 67.26 | 1744 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-129-5P | 99.88 | 70.26 | 3273 |
| HSA-MIR-4328 | 99.57 | 71.06 | 4094 |
| HSA-MIR-569 | 99.42 | 66.32 | 1009 |
| HSA-MIR-4263 | 99.18 | 69.25 | 2236 |
| HSA-MIR-4725-5P | 98.67 | 65.42 | 628 |
| HSA-MIR-504-5P | 98.67 | 65.40 | 631 |
| HSA-MIR-432-5P | 98.00 | 68.13 | 989 |
| HSA-MIR-10398-5P | 97.12 | 64.94 | 1051 |
| HSA-MIR-4448 | 97.04 | 66.22 | 752 |
| HSA-MIR-1236-5P | 96.62 | 66.38 | 856 |
Literature-anchored findings (GeneRIF, showing 1)
- Defining the interactome of the human mitochondrial ribosome identifies SMIM4 and TMEM223 as respiratory chain assembly factors. (PMID:34969438)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmem223 | ENSDARG00000069494 |
| mus_musculus | Tmem223 | ENSMUSG00000117924 |
| rattus_norvegicus | Tmem223 | ENSRNOG00000019266 |
| drosophila_melanogaster | CG12935 | FBGN0033547 |
Protein
Protein identifiers
Transmembrane protein 223 — A0PJW6 (reviewed: A0PJW6)
All UniProt accessions (3): A0PJW6, G5EA27, H0YCK4
UniProt curated annotations — full annotation on UniProt →
Function. Mitochondrial ribosome-associated protein involved in the first steps of cytochrome c oxidase complex (complex IV) biogenesis. Stimulates the translation of MT-CO1 mRNA and is a constituent of early MT-CO1 assembly intermediates.
Subunit / interactions. Associates with the mitochondrial ribosome.
Subcellular location. Mitochondrion inner membrane.
Similarity. Belongs to the TMEM223 family.
RefSeq proteins (1): NP_001073970* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026100 | Tmem223 | Family |
| IPR045325 | TMEM70/TMEM186/TMEM223 | Family |
Pfam: PF06979
UniProt features (9 total): topological domain 3, transmembrane region 2, sequence variant 2, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0PJW6-F1 | 73.52 | 0.11 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9864848 | Complex IV assembly |
MSigDB gene sets: 117 (showing top):
GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_DN, GOBP_RESPIRATORY_CHAIN_COMPLEX_IV_ASSEMBLY, GOBP_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_ASSEMBLY, GOBP_CYTOCHROME_COMPLEX_ASSEMBLY, GOCC_MITOCHONDRIAL_ENVELOPE, GOCC_ORGANELLE_INNER_MEMBRANE, GOMF_RIBONUCLEOPROTEIN_COMPLEX_BINDING, GOMF_RIBOSOME_BINDING, GOCC_ORGANELLE_ENVELOPE, BRUINS_UVC_RESPONSE_EARLY_LATE, KATSANOU_ELAVL1_TARGETS_UP, BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING, GOMF_PROTEIN_CONTAINING_COMPLEX_BINDING, ATF6_TARGET_GENES, CHAF1B_TARGET_GENES
GO Biological Process (1): mitochondrial respiratory chain complex IV assembly (GO:0033617)
GO Molecular Function (1): mitochondrial ribosome binding (GO:0097177)
GO Cellular Component (3): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Respiratory electron transport | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| mitochondrion | 1 |
| respiratory chain complex IV assembly | 1 |
| mitochondrial respiratory chain complex assembly | 1 |
| ribosome binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
494 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM223 | TMEM53 | Q6P2H8 | 591 |
| TMEM223 | UQCC5 | Q8WVI0 | 577 |
| TMEM223 | TMEM101 | Q96IK0 | 562 |
| TMEM223 | TMEM147 | Q9BVK8 | 540 |
| TMEM223 | TMEM238 | C9JI98 | 525 |
| TMEM223 | TMEM154 | Q6P9G4 | 486 |
| TMEM223 | PIGS | Q96S52 | 484 |
| TMEM223 | PDZK1IP1 | Q13113 | 457 |
| TMEM223 | TMEM38A | Q9H6F2 | 434 |
| TMEM223 | UQCC6 | Q69YU5 | 418 |
| TMEM223 | OXA1L | Q15070 | 391 |
| TMEM223 | GATAD1 | Q8WUU5 | 383 |
| TMEM223 | TMEM183A | Q8IXX5 | 370 |
| TMEM223 | TMEM151A | Q8N4L1 | 370 |
| TMEM223 | COMMD10 | Q9Y6G5 | 366 |
IntAct
86 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KLHL22 | TMEM223 | psi-mi:“MI:0914”(association) | 0.640 |
| TRDN | TMEM223 | psi-mi:“MI:0914”(association) | 0.640 |
| MME | TMEM223 | psi-mi:“MI:0914”(association) | 0.530 |
| KCNA5 | TMEM223 | psi-mi:“MI:0914”(association) | 0.530 |
| SLC7A1 | TMEM223 | psi-mi:“MI:0914”(association) | 0.530 |
| SLC39A5 | TMEM223 | psi-mi:“MI:0914”(association) | 0.530 |
| TOR1AIP2 | TMEM223 | psi-mi:“MI:0914”(association) | 0.530 |
| LPAR1 | TMEM223 | psi-mi:“MI:0914”(association) | 0.530 |
| IPPK | TMEM223 | psi-mi:“MI:0914”(association) | 0.530 |
| PCDHAC2 | TMEM223 | psi-mi:“MI:0914”(association) | 0.530 |
| TMEM223 | TMEM259 | psi-mi:“MI:0915”(physical association) | 0.400 |
| UPK1A | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| CHRNA3 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| ADGRE5 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| PDCD1 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| LRRTM1 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| HTR3C | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (87): TMEM223 (Affinity Capture-MS), TMEM223 (Affinity Capture-MS), TMEM223 (Affinity Capture-MS), TMEM223 (Affinity Capture-MS), TMEM223 (Affinity Capture-MS), TMEM223 (Affinity Capture-MS), MTHFR (Affinity Capture-MS), TMEM223 (Affinity Capture-MS), TMEM223 (Affinity Capture-MS), CTH (Affinity Capture-MS), TMEM223 (Affinity Capture-MS), C3orf52 (Affinity Capture-MS), TMEM223 (Affinity Capture-MS), TMEM223 (Affinity Capture-MS), HLA-C (Affinity Capture-MS)
ESM2 similar proteins: A0PJW6, A5PJW2, B3DI94, B5DFG1, O00411, O95382, P49753, Q059A4, Q0V9C9, Q3SX05, Q4KLZ1, Q4KM93, Q4R5Q4, Q4VAE3, Q53S58, Q5EA71, Q5T1A1, Q5XIC2, Q643R3, Q66LN0, Q6DC58, Q6NVG1, Q76MJ5, Q7YS91, Q80YU0, Q863F8, Q8BPE4, Q8BWM0, Q8N159, Q8NFF5, Q8VCA6, Q8VD26, Q921N7, Q96AN5, Q96KR6, Q99MQ3, Q9BQ95, Q9BUB7, Q9BYK8, Q9CQE2
Diamond homologs: A0PJW6, A5PJW2, Q6DC58, Q9CQE2
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 64 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Cardiac conduction | 5 | 12.4× | 5e-03 |
| Neuronal System | 9 | 9.1× | 9e-05 |
| Muscle contraction | 5 | 8.8× | 1e-02 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| regulation of membrane potential | 5 | 19.9× | 2e-03 |
| monoatomic ion transmembrane transport | 5 | 17.9× | 2e-03 |
| response to endoplasmic reticulum stress | 5 | 14.4× | 2e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
47 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 44 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2731 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:62775769:A:AG | acceptor_gain | 1.0000 |
| 11:62775770:G:GC | acceptor_gain | 1.0000 |
| 11:62775770:GCTCC:G | acceptor_gain | 1.0000 |
| 11:62775898:G:GT | donor_gain | 1.0000 |
| 11:62775926:CGCAG:C | donor_loss | 1.0000 |
| 11:62775927:GCAG:G | donor_gain | 1.0000 |
| 11:62775928:C:T | donor_gain | 1.0000 |
| 11:62775928:CAGGT:C | donor_loss | 1.0000 |
| 11:62775932:T:A | donor_loss | 1.0000 |
| 11:62776378:TCCCA:T | acceptor_loss | 1.0000 |
| 11:62776379:CCCA:C | acceptor_loss | 1.0000 |
| 11:62776380:CCAGA:C | acceptor_loss | 1.0000 |
| 11:62776381:CAGAA:C | acceptor_loss | 1.0000 |
| 11:62776382:A:AG | acceptor_gain | 1.0000 |
| 11:62776382:A:AT | acceptor_loss | 1.0000 |
| 11:62776383:G:GT | acceptor_gain | 1.0000 |
| 11:62776383:GA:G | acceptor_gain | 1.0000 |
| 11:62776383:GAA:G | acceptor_gain | 1.0000 |
| 11:62776383:GAAT:G | acceptor_gain | 1.0000 |
| 11:62776383:GAATA:G | acceptor_gain | 1.0000 |
| 11:62776469:AGGTG:A | donor_loss | 1.0000 |
| 11:62776471:G:GG | donor_gain | 1.0000 |
| 11:62776472:T:G | donor_loss | 1.0000 |
| 11:62778105:G:GT | donor_gain | 1.0000 |
| 11:62778119:GCT:G | donor_gain | 1.0000 |
| 11:62782823:AAG:A | donor_loss | 1.0000 |
| 11:62782824:AG:A | donor_loss | 1.0000 |
| 11:62782825:GGT:G | donor_loss | 1.0000 |
| 11:62782826:G:T | donor_loss | 1.0000 |
| 11:62782827:T:G | donor_loss | 1.0000 |
AlphaMissense
1265 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:62790656:A:C | F192L | 0.988 |
| 11:62790656:A:T | F192L | 0.988 |
| 11:62790658:A:G | F192L | 0.988 |
| 11:62790657:A:C | F192C | 0.984 |
| 11:62791884:A:C | F37L | 0.981 |
| 11:62791884:A:T | F37L | 0.981 |
| 11:62791886:A:G | F37L | 0.981 |
| 11:62790698:G:C | F178L | 0.980 |
| 11:62790698:G:T | F178L | 0.980 |
| 11:62790700:A:G | F178L | 0.980 |
| 11:62790699:A:G | F178S | 0.975 |
| 11:62790654:T:A | D193V | 0.969 |
| 11:62790657:A:G | F192S | 0.967 |
| 11:62791820:A:G | W59R | 0.966 |
| 11:62791820:A:T | W59R | 0.966 |
| 11:62790675:A:G | F186S | 0.964 |
| 11:62790693:A:G | L180S | 0.964 |
| 11:62790764:G:C | C156W | 0.964 |
| 11:62790722:T:A | K170N | 0.959 |
| 11:62790722:T:G | K170N | 0.959 |
| 11:62791860:G:C | F45L | 0.959 |
| 11:62791860:G:T | F45L | 0.959 |
| 11:62791862:A:G | F45L | 0.959 |
| 11:62790658:A:T | F192I | 0.956 |
| 11:62791885:A:C | F37C | 0.956 |
| 11:62790655:C:G | D193H | 0.955 |
| 11:62790765:C:T | C156Y | 0.954 |
| 11:62791841:A:G | C52R | 0.954 |
| 11:62790633:C:G | R200P | 0.952 |
| 11:62790766:A:G | C156R | 0.951 |
dbSNP variants (sampled 300 via entrez): RS1000009827 (11:62780240 C>T), RS1000011074 (11:62780484 C>A,G,T), RS1000067794 (11:62786746 T>C,G), RS1000081793 (11:62786984 T>C), RS1000374223 (11:62791454 T>G), RS1000506168 (11:62775232 A>G), RS1000571143 (11:62777086 G>A), RS1000579824 (11:62784424 C>T), RS1000632081 (11:62784190 A>G,T), RS1000921235 (11:62777438 A>G), RS1001085217 (11:62787648 G>A,C,T), RS1001205308 (11:62771775 G>A), RS1001272030 (11:62787085 C>T), RS1001360268 (11:62778545 T>G), RS1001400844 (11:62781567 G>A,C)
Disease associations
OMIM: gene MIM:620434 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005956_2 | Waist-to-hip ratio adjusted for BMI | 1.000000e-08 |
| GCST005962_51 | Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) | 1.000000e-07 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0008007 | age at assessment |
| EFO:0008343 | sex interaction measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| cylindrospermopsin | increases expression | 1 |
| abrine | decreases expression | 1 |
| jinfukang | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | increases expression | 1 |
| Ethyl Methanesulfonate | decreases expression | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Vincristine | decreases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Sodium Selenite | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | decreases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_TS92 | HAP1 TMEM223 (-) 1 | Cancer cell line | Male |
| CVCL_TS93 | HAP1 TMEM223 (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.